176 related articles for article (PubMed ID: 21317646)
1. The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.
Li Y; Sun JF; Cui X; Mani H; Danner RL; Li X; Su JW; Fitz Y; Eichacker PQ
Crit Care Med; 2011 May; 39(5):1104-12. PubMed ID: 21317646
[TBL] [Abstract][Full Text] [Related]
2. Antagonic effect of the inhibition of inducible nitric oxide on the mortality of mice acutely infected with Escherichia coli and Bacteroides fragilis.
Astolfi RS; Khouri DG; Brandizzi LI; Avila-Campos MJ; Andrade HF
Braz J Med Biol Res; 2007 Mar; 40(3):317-22. PubMed ID: 17334528
[TBL] [Abstract][Full Text] [Related]
3. Heparin treatment of live Escherichia coli bacteremia in rats.
Horwitz DL; Ballantine TV; Coran AG; Herman CM
J Surg Res; 1972 Sep; 13(3):120-5. PubMed ID: 4563151
[No Abstract] [Full Text] [Related]
4. Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.
Weiner DL; Kuppermann N; Saladino RA; Thompson CM; Novitsky TJ; Siber GR; Fleisher GR
Crit Care Med; 1996 Sep; 24(9):1514-7. PubMed ID: 8797624
[TBL] [Abstract][Full Text] [Related]
5. Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model.
Cui X; Parent C; Macarthur H; Ochs SD; Gerstenberg E; Solomon S; Fitz Y; Danner RL; Banks SM; Natanson C; Salvemini D; Eichacker PQ
J Appl Physiol (1985); 2004 Oct; 97(4):1349-57. PubMed ID: 15169752
[TBL] [Abstract][Full Text] [Related]
6. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.
Shen WC; Wang X; Qin WT; Qiu XF; Sun BW
Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652
[TBL] [Abstract][Full Text] [Related]
7. Detrimental effects of a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine-methyl-ester) in a murine sepsis model.
Fukatsu K; Saito H; Fukushima R; Inoue T; Lin MT; Inaba T; Muto T
Arch Surg; 1995 Apr; 130(4):410-4. PubMed ID: 7710342
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
Ueda T; Fukunaga K; Seki H; Miyata J; Arita M; Miyasho T; Obata T; Asano K; Betsuyaku T; Takeda J
Crit Care Med; 2014 Apr; 42(4):e288-95. PubMed ID: 24463858
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice.
Kinoshita M; Seki S; Ono S; Shinomiya N; Hiraide H
Ann Surg; 2004 Aug; 240(2):313-20. PubMed ID: 15273557
[TBL] [Abstract][Full Text] [Related]
11. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
Kearon C; Harrison L; Crowther M; Ginsberg JS
Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
[TBL] [Abstract][Full Text] [Related]
12. A Neonatal Murine
Speer EM; Diago-Navarro E; Ozog LS; Raheel M; Levy O; Fries BC
Front Immunol; 2020; 11():577878. PubMed ID: 33072121
[No Abstract] [Full Text] [Related]
13. Binge alcohol consumption 18 h after induction of sepsis in a mouse model causes rapid overgrowth of bacteria, a cytokine storm, and decreased survival.
Bhatty M; Tan W; Basco M; Pruett S; Nanduri B
Alcohol; 2017 Sep; 63():9-17. PubMed ID: 28847384
[TBL] [Abstract][Full Text] [Related]
14. Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic septicaemia infection mouse model.
Knappe D; Fritsche S; Alber G; Köhler G; Hoffmann R; Müller U
J Antimicrob Chemother; 2012 Oct; 67(10):2445-51. PubMed ID: 22729924
[TBL] [Abstract][Full Text] [Related]
15. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
[TBL] [Abstract][Full Text] [Related]
16. The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release.
Wang J; Zhou H; Zheng J; Cheng J; Liu W; Ding G; Wang L; Luo P; Lu Y; Cao H; Yu S; Li B; Zhang L
Antimicrob Agents Chemother; 2006 Jul; 50(7):2420-7. PubMed ID: 16801421
[TBL] [Abstract][Full Text] [Related]
17. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.
Stack AM; Saladino RA; Thompson C; Sattler F; Weiner DL; Parsonnet J; Nariuchi H; Siber GR; Fleisher GR
Crit Care Med; 1995 Sep; 23(9):1512-8. PubMed ID: 7664553
[TBL] [Abstract][Full Text] [Related]
18. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of early administration of low-dose heparin in patients with severe sepsis].
Zhang XJ; Ma XC
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1209-11. PubMed ID: 17147870
[TBL] [Abstract][Full Text] [Related]
20. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
Eur Heart J; 1999 Nov; 20(22):1657-66. PubMed ID: 10543929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
